Progress in the Treatment of Myelofibrosis

Listen Now

Topics Covered

• Overview & Updates on Myelofibrosis (MF), in the Context of COVID-19
• Staging & Diagnosing
• Current Standard of Care
• New & Emerging Treatment Approaches
• Understanding Common Signs & Symptoms
• Strategies to Reduce Potential Complications of MF
• Clinical Trial Updates
• How Research Contributes to Your Treatment Options
• Working with Your Health Care Team to Manage Symptoms, Treatment Side Effects, Discomfort & Pain
• The Importance of Adherence to Treatment
• Communicating with Your Health Care Team about Staging & Progression
• Talking with Your Doctor about What Symptoms Should Prompt You or Your Caregiver to Call the Office
• Quality-of-Life Concerns & Recommendations to Improve Your Quality-of-Life
• Guidelines to Prepare for Telehealth Appointments with Your Health Care Team, including Technology & Prepared List of Questions
• Questions for Our Panel of Experts

Our Panel of Experts

Aaron T. Gerds, MD, MS

Associate Professor of Medicine, Hematology & Medical Oncology, Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute, Medical Director, Case Comprehensive Cancer Center Clinical Research Office

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 16, 2021.